Paul Tudor Jones's WGS Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 33,540 shares of GeneDx Holdings Corp. (WGS) worth $2.15 M, representing 0.00% of the portfolio. First purchased in 2024-Q2, this short-term holding has been held for 8 quarters.
Based on 13F filings, Paul Tudor Jones has maintained this position in WGS for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 68,654 shares. Largest reduction occurred in Q1 2025, reducing 93,889 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's GeneDx Holdings (WGS) Holding Value Over Time
Track share changes against reported price movement
Quarterly GeneDx Holdings (WGS) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +33,540 | New Buy | 33,540 | $64.22 |
| Q4 2025 | -68,654 | Sold Out | 0 | $0.00 |
| Q3 2025 | +68,654 | New Buy | 68,654 | $107.74 |
| Q2 2025 | -7,921 | Sold Out | 0 | $0.00 |
| Q1 2025 | -93,889 | Reduce 92.22% | 7,921 | $88.56 |
| Q4 2024 | +41,084 | Add 67.65% | 101,810 | $76.86 |
| Q3 2024 | -30,761 | Reduce 33.62% | 60,726 | $42.44 |
| Q2 2024 | +91,487 | New Buy | 91,487 | $26.14 |
Paul Tudor Jones's GeneDx Holdings Investment FAQs
Paul Tudor Jones first purchased GeneDx Holdings Corp. (WGS) in Q2 2024, acquiring 91,487 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held GeneDx Holdings Corp. (WGS) for 8 quarters since Q2 2024.
Paul Tudor Jones's largest addition to GeneDx Holdings Corp. (WGS) was in Q2 2024, adding 91,487 shares worth $2.39 M.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 33,540 shares of GeneDx Holdings Corp. (WGS), valued at approximately $2.15 M.
As of the Q1 2026 filing, GeneDx Holdings Corp. (WGS) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in GeneDx Holdings Corp. (WGS) was 101,810 shares, as reported at the end of Q4 2024.